APA

Bukan K. B., Nardo-Marino A., Hagdrup C., Boennelycke M., Breinholdt M. F., Schöllkopf C., Nielsen H. V. & El Fassi D. (20191105). Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy. : Scandinavian journal of rheumatology.

Chicago

Bukan K B, Nardo-Marino A, Hagdrup C, Boennelycke M, Breinholdt M F, Schöllkopf C, Nielsen H V and El Fassi D. 20191105. Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy. : Scandinavian journal of rheumatology.

Harvard

Bukan K. B., Nardo-Marino A., Hagdrup C., Boennelycke M., Breinholdt M. F., Schöllkopf C., Nielsen H. V. and El Fassi D. (20191105). Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy. : Scandinavian journal of rheumatology.

MLA

Bukan K B, Nardo-Marino A, Hagdrup C, Boennelycke M, Breinholdt M F, Schöllkopf C, Nielsen H V and El Fassi D. Haemophagocytic lymphohistiocytosis associated with leishmaniasis reactivation: a potential adverse event to anti-tumour necrosis factor-α therapy. : Scandinavian journal of rheumatology. 20191105.